New drugs blast budgets. Patients benefit; hospital pharmacies weigh options. [electronic resource]
- Modern healthcare Jun 1998
- 36 p. digital
Publication Type: Journal Article
0160-7480
Abciximab Angina Pectoris--drug therapy Antibodies, Monoclonal--economics Anticoagulants--economics Drug Approval Drug Costs--trends Eptifibatide Humans Immunoglobulin Fab Fragments--economics Peptides--economics Pharmacy Service, Hospital--economics Tirofiban Tyrosine--analogs & derivatives United States United States Food and Drug Administration